Julia Vitarello and Dr. Tim Yu speak with Richard Scott of Genomics England about Mila’s powerful story - her diagnostic odyssey and bespoke treatment, the importance of newborn screenings for rare disease drug development, and their continued pursuit to pave a path for more n-of-1 treatments like milasen - as they move from Mila to Millions.